Emily Graham is a Senior Manager of Innovation at Stanford HealthCare where she partners with startups to pilot new business models and technologies in the clinical setting. She evaluates partnership opportunities based on their strategic fit with Stanford's needs, unique potential to impact health outcomes and drive efficiencies in care. Prior to joining Stanford HealthCare, Emily was a Director of Corporate Digital Strategy where she developed a strategy to leverage emerging digital technology to support Pfizer's global pharma business transformation, and before that, was a member of the Worldwide Innovation Group where she collaborated across the organization to build a global innovation platform for originating and incubating disruptive business models from ideation to implementation. Previously, she was with Credit Suisse where she covered Specialty Pharma Equities and before that, was a Market Strategist at Genentech. She holds a MBA from Harvard Business School and a BS from U.C. Berkeley.